Health Consumer Councils across Australia, including HCA have released a joint media statement in response to the Therapeutic Goods Administration (TGA) action on mesh. As the state/territory peak health consumer organisations, we have added our voices to those of women across Australia, calling for the banning of mesh. You can read the full media release below.Health Consumer Councils across Australia have released a joint media statement in response to the Therapeutic Goods Administration (TGA) action on mesh. As the state/territory peak health consumer organisations we have added our voices to those of mesh-damaged women across Australia calling for the banning of mesh. We congratulate these women on the impact of their strong lobbying with the historic decision by the TGA to remove some mesh products (POP mesh and mini-slings) from their register of approved devices. This move has been celebrated by mesh-damaged women around the world. You can read the full media statement below.
A new regulatory framework for surgical mesh devices and provision of information to the consumers for all implantable medical devices has been approved by the Minister for Health, the Hon Greg Hunt. The changes are intended to maintain the alignment of the Australian regulatory framework with similar initiatives recently announced in Europe. They are another step in the implementation of the broader regulatory reform agenda set by the Review of the Medicines and Medical Devices Regulations. You can read more detail on the Therapeutic Goods Administration website here.
A story on ABC's Lateline at 9:30pm on Monday 14 August 2017 reveals that documents obtained by the ABC show the extent to which Johnson and Johnson oversold its surgical mesh products, which are used to treat incontinence and prolapse after childbirth. Find out more here.
HCA and our fellow health consumer organisations from across Australia launched a national campaign to understand the impact of pelvic mesh, tape or sling implants, which concluded Wednesday 31 May 2017. The Joint submission by Health Consumers Councils across Australia to the Senate Inquiry into the number of women in Australia who have had transvaginal mesh implants and related matters is now available below. All submissions made are available to view here.
The Australian Commission on Safety and Quality in Healthcare, following a request from state and territory health department representatives, is developing guidance for consumers, clinicians and health services on the use of transvaginal mesh products for the treatment of pelvic organ prolapse and stress urinary incontinence.
As part of this project, the Commission is reviewing the existing evidence on the use of transvaginal mesh and is working with a reference group that includes a range of clinical experts, consumer representatives and the Therapeutic Goods Administration. You can find out more by visiting their website here.
The March HCASA Board meeting recently confirmed our capacity to continue our work well into 2020. HCASA is here to stay. We had expected to call a Special General Meeting at about this time to ask our members to consider the organisation’s future. After careful consideration of our financial position, our capacity and the importance of our work we are instead scheduling the launch of our new business prospectus. This is planned for Monday 17 June, Save the date.
You will have read in eNews that we have moved our offices upstairs from level 1 to 3 at 12 Pirie Street. Our team continues to do an amazing job building a viable and sustainable business future. You’ll hear more about this on/after 17 June. We would not have been able to consider such an optimistic future without the pragmatic and moral support of our members, partners and supporters. Thank you.
We encourage organisations and individuals who believe in our vision of ‘consumers at the centre of health’ to make sure they have current membership of HCASA. As you know, we are a state-wide, member-based incorporated association with no political affiliations. We provide the information, training and services people, services and policy makers need to ensure consumers have a powerful influence on the health services that they pay for, use and expect to support the health and wellbeing of all South Australians. This work must and will continue.
Debra Kay PSM
Board Chair HCASA
On behalf of the HCASA Board and Staff Team
There have been some changes at the Health and Community Service Complaints Commissioner (HCSCC). On 18 March 2019, South Australia implemented the Code of Conduct for Certain Health Care Workers which replaced the Code of Conduct for Unregistered Health Practitioners. This change aligns South Australia with the National Code of Conduct for Health Care Workers approved by the COAG Health Council. Unregistered health care workers who do not fall within the jurisdiction of the Australian Health Practitioner Regulation Agency (AHPRA) will have to comply with the code and display certain information where they practise.
The code establishes:
• A range of minimum standards for unregistered health care workers.
• Additional powers to the HCSCC if an unregistered health care worker is found to have breached the Code.
Law changes also came into effect that allow the Health and Community Services Complaints Commissioner to:
• Adopt prohibition orders imposed on individuals from across Australia.
• Investigate individual volunteers providing a health service.
• Restrict people who are subject to a prohibition order from advertising and promoting themselves as a health service.
• Issue a public statement to identify a person or warn the public when interim action has been taken.
You’ll also notice that the HCSCC has a new website, which the Health Consumer’s Alliance was consulted on. The new website is easier to navigate, provides clearer information and is consumer tested. Go check it out!
In 2019 HCA will work with consumers, partner agencies and other stakeholders to develop more focused training modules for consumers on topics such as:
One of the changes of not having a core funding base is that we will now be charging for our training, including consumer training. Fees will be kept as low as possible, and opportunities for subsidised training will be made available to consumers who do not have the capacity to pay.
Back to eNews here
Back to eNews here.
The Third Australian Atlas of Healthcare Variation, released 11 December 2018, investigates healthcare use in four clinical areas: paediatric and neonatal health, cardiac tests, thyroid investigations and treatments, and gastrointestinal investigations and treatments. It also examines national patterns in medicines use over time for four common groups of medicines: antipsychotics, opioids, antimicrobials and medications for attention deficit hyperactivity disorder (ADHD). A more detailed exploration of these data will be published in 2019.
Find out more here
Back to eNews here.
Thursday 30 May 2019
The 2019 annual Choosing Wisely National Meeting will bring together policy makers, consumers and other health care stakeholders for an interactive discussion on the opportunities, challenges, and highlights of the Choosing Wisely initiative as it continues to grow. Early bird registration is open until Thursday 18 April.
Find out more and register here.
Wednesday 30 January 2019
10am – 12pm
HCA is hosting a focus group for the South Australian Health and Community Services Complaints Commissioner (HCSCC). The focus group aims to gain consumer feedback on their current website to ensure it is user-friendly.
You can find out more and register here.
Back to eNews here.
Thursday 30 May 2019
The annual 2019 Choosing Wisely National Meeting will bring together policymakers, consumers and other health care stakeholders for an interactive discussion on the opportunities, challenges, and highlights of the choosing wisely initiative as it continues to grow. Early bird registration is open until Thursday 18 April. You can find out more about the meeting and the Choosing Wisely initiative here.